Neuroradiological features of six kindreds with MELAS tRNALeu A3243G point mutation: Implications for pathogenesis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 2, 1998, Pages 233-240

  Sue, C M ^a,d   Crimmins, D S ^a   Soo, Y S ^b   Pamphlett, R ^a   Presgrave, C M ^a   Kotsimbos, N ^c   Jean Francois, M J B ^c   Byrne, E ^c   Morris, J G L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Columbia University ^*  (United States)

Author keywords

A3243G point mutation; MELAS; Mitochondrial DNA; Neuroradiology

Indexed keywords

TRANSFER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN FOURTH VENTRICLE; BRAIN VENTRICLE DILATATION; CEREBELLUM; CEREBELLUM ATROPHY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FAHR DISEASE; FEMALE; GENETIC ANALYSIS; GLOBUS PALLIDUS; GRAY MATTER; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MELAS SYNDROME; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BASAL GANGLIA; BRAIN; CALCINOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MELAS SYNDROME; MIDDLE AGED; NEUROLOGIC EXAMINATION; PEDIGREE; POINT MUTATION; RNA, TRANSFER, LEU; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031874059     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.2.233     Document Type: Article

References (55)

1. Petty RKH, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy. Brain 1986;109:915-38.
2. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16:481-8.
3. Crimmins D, Morris JGL, Walker GL, et al. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Psychiatry 1993;56:900-5.
4. Goto Y, Nonaku I, Horai S. A mutant in the tRNA leucine gene associated with the MELAS subgroup of mitochondrial encephalopathies. Nature 1990;348:651-3.
5. Goto Y, Nonaka I, Horai S. A new mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991;1097:238-40.
6. Lertrit P, Noer AS, Jean-Francois MJB, et al. A new disease related mutation for mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome affects the ND4 subunit of the respiratory complex I. Am J Hum Genet 1992;51:457-68.
7. Shoffner JM, Lott MT, Lezza AMS, et al. Myoclonic epilepsy and ragged red fibre disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990;61:931-7.
8. Silvestri G, Moraes CT, Shanske S, et al. A new mutation in the tRNA(Lys) gene associated with myoclonus epilepsy, ragged red fibres (MERRF). Am J Hum Genet 1992;51: 1213-7.
9. Schon EA, Rizzuto R, Moraes CT, et al. A direct repeat is a hot spot for large scale deletions of human mitochondrial DNA. Science 1989;244:346-9.
10. Egger J, Kendall BE. Computed tomography in mitochondrial cytopathy. Neuroradiology 1981;22:73-8.
11. Barkovich AJ, Good WV, Koch TK, et al. Mitochondrial disorders: analysis of their clinical and imaging characteristics. Am J Neuroradiol 1993;14:1119-37.
12. Allard JC, Tilak S, Carter AP. CT and MR of MELAS syndrome. Am J Neuroradiol 1988;9:1234-8.
13. Kendall BE. Disorders of lysosomes, peroximes, and mitochondria. Am J Neuroradiol 1992;13:621-39.
14. Kotsimbos N, Jean-Francois MJB, Huizing M, et al. Rapid and non-invasive screening of patients with mitochondrial myopathy. Hum Mutat 1994;4:132-5.
15. Evans WA. An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol 1942;47:931-7.
16. Lowenthal A. Striopallidodentate calcifications. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Amsterdam: Elsevier, 1986:417-36.
17. Toppet M, Telerman-Toppet N, Szliwowski HB, et al. Oculocraniosomatic neuromuscular disease with hypoparathyroidism. Am J Dis Child 1977;131:437-41.
18. Slager UT, Wagner JA. The incidence, composition, and pathological significance of intracerebral vascular deposits in the basal ganglia. J Neuropathol Exp Neurol 1956;15:417-31.
19. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: a possible factor in ageing. Lancet 1989;i:637-9.
20. Midroni G, Willinsky R. Rapid postanoxic calcification of the basal ganglia. Neurology 1992;42:2144-6.
21. Kingley DPE, Kendall BE. CT of the adverse effects of therapeutic radiation of the central nervous system. Am J Neurorad 1981;2:453-60.
22. Halpern J P, Boyages SC, Maberly GF, et al. The neurology of endemic cretinism. A study of two endemias. Brain 1991;114:825-41.
23. Neumann MA. Iron and calcium dysmetabolism in the brain. J Neuropathol Exp Neurol 1963;22:148-63.
24. Borle A. Calcium metabolism at the cellular level. Fed Proc 1979;32:1944-50.
25. Anderson HC. Mechanisms of pathological calcification. Rheum Dis Clin North Am 1988;14:303-19.
26. Kishi M, Yamamura Y, Kuriharra T, et al. An autopsy case of mitochondrial encephalopathy: biochemical and electron microscopic studies of the brain. J Neurol Sci 1988;86:31-40.
27. Muenter M, Whisnant JP. Basal ganglia calcification, hypothyroidism, and extrapyramidal motor manifestations. Neurology 1968;18:1075-83.
28. Messimy R, Diebler C, Metzger J. Dystonie de torsion du membre superieur gauche probablement consecutive a un traumatisme cranien. Rev Neurol (Paris) 1977;133:199-206.
29. Harrington M G, Macpherson P, Mcintosh W, et al. The significance of the incidental finding of basal ganglia calcification on computed tomography. J Neurol Neurosurg Psychiatry 1981;44:1168-70.
30. Koller WC, Cochran JW, Klawans HL. Calcification of the basal ganglia: computerized tomography and clinical correlation. Neurology 1979;29:328-33.
31. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits; neural substrates of parallel processing. Trend Neurosci 1990;13:266-71.
32. Reynolds SF, Blass JP. A possible mechanism for selective cerebellar damage in partial pyruvate dehydrogenase deficiency. Neurology 1976;26:625-8.
33. Hasuo K, Tamura S, Yasumori K, et al. Computed tomography and angiography in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes); report of three cases. Neuroradiology 1987;29: 393-7.
34. Matthews PM, Andermann F, Silver K, et al. Proton MR spectroscopic characterisation of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43:2484-90.
35. Harding AE, Schapira AHV. Mitochondrial disease and movement disorders. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins, 1993.
36. Kuriyama M, Umezaki H, Fukuda Y, et al. Mitochondrial encephalomyopathy with lactate-pyruvate elevation and brain infarctions. Neurology 1984;34:72-7.
37. Yamamoto T, Beppu H, Tsubaki T. Mitochondrial encephalopathy: fluctuating symptoms and CT. Neurology 1984;34:1456-60.
38. Leu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology 1991; 41:1663-5.
39. Love S, Nicoll A R, Kinrade E. Sequencing and quantitative assessment of mutant and wild-type mitochondrial DNA in paraffin sections from cases of MELAS. J Pathol 1993;170: 9-14.
40. Shoji Y, Sato W, Hayasaka K, et al. Tissue distribution of mutant mitochondrial DNA in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. J Inherit Metab Dis 1993;16:27-30.
41. Olesen J, Larsen B, Lauritzen M. Focal hyperaemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-52.
42. Lauritzen M, Skyhoj Olsen T, Larsson NA, et al. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983;13:633-41.
43. Morita K, Ono S, Fukunaga M, et al. Increased accumulation of n-isopropyl-p-(I-123)iodoamphetamine in two cases with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Neuroradiology 1989;31:358-61.
44. Satoh M, Ishikawa N, Yoshizawa T, et al. N-isopropyl-p-[123I]iodoamphetamine SPECT in MELAS syndrome: comparison with CT and MR imaging. J Comput Assist Tomogr 1991;15:77-91.
45. Goto Y. Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 1995;(suppl 3):S107-12.
46. Chiras J, Dubs M, Bories J. Venous infarction. Neuroradiology 1985;27:593-600.
47. Ooiwa Y, Uematsu Y, Terada T, et al. Cerebral blood flow in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Stroke 1993;24:304-9.
48. Sakuta R, Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989;25:594-601.
49. Tokunaga M, Mita S, Sakuta R, et al. Increased mitochondrial DNA in blood vessels and ragged-red fibres in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Ann Neurol 1993;33: 275-80.
50. Hasegawa, Matsuoka T, Goto Y, et al. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Ann Neurol 1991;29:601-5.
51. Matsuoka T, Hasegawa T, Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels (SSV) in various neuromuscular diseases. Clin Neurol 1992;32:645-7.
52. Donnan GA, Nrving B, Bamford JM, et al. Subcortical infarction: classification and terminology. Cerebrovasc Dis 1993;3:248-51.
53. De Volder A, Ghilain S, de Barsy T, et al. Brain metabolism in mitochondrial encephalopathy: a PET Study. J Comput Assist Tomography 1988;12:854-7.
54. Taverni N, Dal Pozzo G, Arnetoli G, Zappoli R. Diagnosis and follow-up of mitochondrial encephalomyopathy: CT and MR studies. J Comput Assist Tomogr 1988;12:696-7.
55. Rosen L, Phillips S, Enzmann D. Magnetic resonance imaging in MELAS syndrome. Neuroradiology 1990;32:168-71.